Back to Screener

Healthcare

Genomma Lab Internacional, S.A.B. de C.V.(GNMLF)

Live Price

Offline

$0.8368

+0.00% today

1Y Change

-26.32%

Window

Jun 26, 2025 β†’ Jun 19, 2026

Market Cap
$16.17B
Revenue Growth
+9.0%
EPS Growth
-94.0%
Dividend Yield
4.8%

Coverage: 252 bars Β· Jun 26, 2025 β†’ Jun 19, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is a Healthcare stock with a market cap of $16.17B and listed on OTC. The stock last traded around $0.84 and down 26.3% across the available one-year price window (Jun 26, 2025 β†’ Jun 19, 2026). Baseline metrics include revenue growth of +9.0%, EPS growth of -94.0%, a dividend yield of 4.8%. What stands out right now is revenue +9.0%, EPS -94.0%, free cash flow -51.7% with operating margin 21.2% and ROIC 14.4%. The dividend matters to the case here, with a current yield around 4.8%. Valuation is more restrained than many high-expectation growth names at P/E 9.7 and price/sales 0.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines GNMLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GNMLF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GNMLF

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

GNMLF Max Drawdown

-28.21%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GNMLF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedApr 29, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
Apr 29, 26
β€”
Est 0.03
β€”
β€”
Est 12547.6B
β€”
Apr 29
β€”
Feb 25, 26
βœ—
0.02
Est 0.02
-17.9%
222823.0B
Est 232918.3B
-4.3%
Feb 25
β€”
Oct 23, 25
βœ—
0.02
Est 0.03
-13.7%
242286.9B
Est 251435.1B
-3.6%
Oct 23
β€”
Jul 22, 25
βœ—
0.00
Est 0.03
-96.3%
13369.2B
Est 251207.4B
-94.7%
Jul 22
β€”
Apr 30, 25
βœ“
0.02
Est 0.02
+19.8%
213674.2B
Est 237289.6B
-9.9%
Apr 30
β€”
Feb 27, 25
βœ—
0.02
Est 0.03
-17.2%
223774.9B
Est 230716.8B
-3.0%
Feb 27
β€”
Oct 23, 24
βœ—
0.00
Est 0.03
-93.4%
259418.5B
Est 236453.6B
+9.7%
Oct 23
β€”
Jul 24, 24
βœ—
0.00
Est 0.02
-91.3%
13855.9B
Est 240342.3B
-94.2%
Jul 24
β€”
Apr 24, 24
βœ—
0.00
Est 0.02
-93.4%
15227.1B
Est 236143.9B
-93.5%
Apr 24
β€”
Feb 22, 24
βœ—
-0.00
Est 0.01
-103.5%
12003.6B
Est 223289.7B
-94.6%
Feb 22
β€”
Sep 30, 23
βœ—
0.00
Est 0.02
-94.7%
14338.5B
Est 248311.9B
-94.2%
Sep 30
β€”
Jun 30, 23
βœ—
0.00
Est 0.02
-93.5%
14905.0B
Est 258449.2B
-94.2%
Jun 30
β€”
Mar 31, 23
βœ—
0.00
Est 0.02
-94.5%
12790.8B
Est 232879.3B
-94.5%
Mar 31
β€”
Feb 22, 23
βœ—
0.27
Est 0.39
-30.8%
10899.2B
Est 218157.4B
-95.0%
Feb 22
β€”
Oct 26, 22
βœ—
0.40
Est 0.43
-7.0%
10694.2B
Est 219044.4B
-95.1%
Oct 26
β€”
Jul 27, 22
βœ—
0.40
Est 0.43
-7.0%
10636.0B
Est 210792.9B
-95.0%
Jul 27
β€”
Apr 27, 22
βœ—
0.34
Est 0.45
-24.4%
10150.2B
Est 201130.2B
-95.0%
Apr 27
β€”
Feb 23, 22
βœ—
0.36
Est 0.41
-12.2%
9694.7B
Est 184051.5B
-94.7%
Feb 23
β€”
Oct 27, 21
βœ—
0.39
Est 0.42
-7.1%
9400.2B
Est β€”
β€”
Oct 27
β€”
Jul 28, 21
βœ—
0.38
Est 0.40
-5.0%
9749.4B
Est β€”
β€”
Jul 28
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener